| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | translation activator activity | 1.20e-08 | 15 | 36 | 4 | GO:0008494 | |
| GeneOntologyMolecularFunction | translation regulator activity, nucleic acid binding | 1.67e-06 | 112 | 36 | 5 | GO:0090079 | |
| GeneOntologyMolecularFunction | mRNA 3'-UTR binding | 1.29e-04 | 276 | 36 | 5 | GO:0003730 | |
| GeneOntologyMolecularFunction | transcription coactivator activity | 2.00e-04 | 303 | 36 | 5 | GO:0003713 | |
| GeneOntologyMolecularFunction | AP-2 adaptor complex binding | 2.84e-04 | 14 | 36 | 2 | GO:0035612 | |
| GeneOntologyMolecularFunction | chromatin binding | 3.02e-04 | 739 | 36 | 7 | GO:0003682 | |
| GeneOntologyMolecularFunction | transcription coregulator activity | 4.59e-04 | 562 | 36 | 6 | GO:0003712 | |
| GeneOntologyMolecularFunction | nuclear glucocorticoid receptor binding | 5.88e-04 | 20 | 36 | 2 | GO:0035259 | |
| GeneOntologyMolecularFunction | peroxisome proliferator activated receptor binding | 6.49e-04 | 21 | 36 | 2 | GO:0042975 | |
| GeneOntologyMolecularFunction | translation regulator activity | 1.12e-03 | 443 | 36 | 5 | GO:0045182 | |
| GeneOntologyMolecularFunction | histone binding | 1.28e-03 | 265 | 36 | 4 | GO:0042393 | |
| GeneOntologyMolecularFunction | acetylation-dependent protein binding | 1.42e-03 | 31 | 36 | 2 | GO:0140033 | |
| GeneOntologyMolecularFunction | bHLH transcription factor binding | 2.02e-03 | 37 | 36 | 2 | GO:0043425 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor binding | 3.69e-03 | 582 | 36 | 5 | GO:0140297 | |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | 4.15e-03 | 1160 | 36 | 7 | GO:0030674 | |
| GeneOntologyMolecularFunction | nuclear receptor binding | 4.60e-03 | 187 | 36 | 3 | GO:0016922 | |
| GeneOntologyMolecularFunction | modification-dependent protein binding | 6.01e-03 | 206 | 36 | 3 | GO:0140030 | |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | 6.08e-03 | 1244 | 36 | 7 | GO:0000978 | |
| GeneOntologyMolecularFunction | RNA polymerase II-specific DNA-binding transcription factor binding | 6.51e-03 | 417 | 36 | 4 | GO:0061629 | |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | 6.82e-03 | 1271 | 36 | 7 | GO:0000987 | |
| GeneOntologyMolecularFunction | mRNA binding | 7.72e-03 | 694 | 36 | 5 | GO:0003729 | |
| GeneOntologyMolecularFunction | p53 binding | 8.49e-03 | 77 | 36 | 2 | GO:0002039 | |
| GeneOntologyMolecularFunction | molecular adaptor activity | 9.61e-03 | 1356 | 36 | 7 | GO:0060090 | |
| GeneOntologyMolecularFunction | promoter-specific chromatin binding | 9.81e-03 | 83 | 36 | 2 | GO:1990841 | |
| GeneOntologyMolecularFunction | transcription factor binding | 1.08e-02 | 753 | 36 | 5 | GO:0008134 | |
| GeneOntologyBiologicalProcess | female meiosis II | 1.17e-10 | 6 | 36 | 4 | GO:0007147 | |
| GeneOntologyBiologicalProcess | meiosis II | 1.17e-10 | 6 | 36 | 4 | GO:0007135 | |
| GeneOntologyBiologicalProcess | meiosis II cell cycle process | 1.17e-10 | 6 | 36 | 4 | GO:0061983 | |
| GeneOntologyBiologicalProcess | positive regulation of meiotic nuclear division | 1.14e-07 | 26 | 36 | 4 | GO:0045836 | |
| GeneOntologyBiologicalProcess | positive regulation of translational initiation | 1.80e-07 | 29 | 36 | 4 | GO:0045948 | |
| GeneOntologyBiologicalProcess | positive regulation of translation | 2.26e-07 | 151 | 36 | 6 | GO:0045727 | |
| GeneOntologyBiologicalProcess | 3'-UTR-mediated mRNA stabilization | 2.38e-07 | 31 | 36 | 4 | GO:0070935 | |
| GeneOntologyBiologicalProcess | positive regulation of meiotic cell cycle | 4.95e-07 | 37 | 36 | 4 | GO:0051446 | |
| GeneOntologyBiologicalProcess | regulation of meiotic nuclear division | 1.11e-06 | 45 | 36 | 4 | GO:0040020 | |
| GeneOntologyBiologicalProcess | oocyte maturation | 1.32e-06 | 47 | 36 | 4 | GO:0001556 | |
| GeneOntologyBiologicalProcess | female meiotic nuclear division | 1.99e-06 | 52 | 36 | 4 | GO:0007143 | |
| GeneOntologyBiologicalProcess | positive regulation of nuclear division | 8.70e-06 | 75 | 36 | 4 | GO:0051785 | |
| GeneOntologyBiologicalProcess | mRNA stabilization | 9.66e-06 | 77 | 36 | 4 | GO:0048255 | |
| GeneOntologyBiologicalProcess | regulation of meiotic cell cycle | 1.24e-05 | 82 | 36 | 4 | GO:0051445 | |
| GeneOntologyBiologicalProcess | negative regulation of mRNA catabolic process | 1.57e-05 | 87 | 36 | 4 | GO:1902373 | |
| GeneOntologyBiologicalProcess | RNA stabilization | 1.64e-05 | 88 | 36 | 4 | GO:0043489 | |
| GeneOntologyBiologicalProcess | regulation of translational initiation | 1.87e-05 | 91 | 36 | 4 | GO:0006446 | |
| GeneOntologyBiologicalProcess | oocyte development | 2.61e-05 | 99 | 36 | 4 | GO:0048599 | |
| GeneOntologyBiologicalProcess | negative regulation of RNA catabolic process | 2.83e-05 | 101 | 36 | 4 | GO:1902369 | |
| GeneOntologyBiologicalProcess | oocyte differentiation | 3.05e-05 | 103 | 36 | 4 | GO:0009994 | |
| GeneOntologyBiologicalProcess | negative regulation of mRNA metabolic process | 4.71e-05 | 115 | 36 | 4 | GO:1903312 | |
| GeneOntologyBiologicalProcess | positive regulation of reproductive process | 5.20e-05 | 118 | 36 | 4 | GO:2000243 | |
| GeneOntologyBiologicalProcess | meiotic nuclear division | 5.75e-05 | 240 | 36 | 5 | GO:0140013 | |
| GeneOntologyBiologicalProcess | translational initiation | 8.05e-05 | 132 | 36 | 4 | GO:0006413 | |
| GeneOntologyBiologicalProcess | cell maturation | 9.50e-05 | 267 | 36 | 5 | GO:0048469 | |
| GeneOntologyBiologicalProcess | meiotic cell cycle process | 9.67e-05 | 268 | 36 | 5 | GO:1903046 | |
| GeneOntologyBiologicalProcess | positive regulation of Notch signaling pathway | 1.08e-04 | 53 | 36 | 3 | GO:0045747 | |
| GeneOntologyBiologicalProcess | positive regulation of gene expression | 1.31e-04 | 1446 | 36 | 10 | GO:0010628 | |
| GeneOntologyBiologicalProcess | regulation of mRNA stability | 1.45e-04 | 292 | 36 | 5 | GO:0043488 | |
| GeneOntologyBiologicalProcess | oogenesis | 1.54e-04 | 156 | 36 | 4 | GO:0048477 | |
| GeneOntologyBiologicalProcess | regulation of RNA stability | 1.85e-04 | 308 | 36 | 5 | GO:0043487 | |
| GeneOntologyBiologicalProcess | regulation of mRNA catabolic process | 1.88e-04 | 309 | 36 | 5 | GO:0061013 | |
| GeneOntologyBiologicalProcess | regulation of translation | 1.94e-04 | 494 | 36 | 6 | GO:0006417 | |
| GeneOntologyBiologicalProcess | regulation of nuclear division | 2.23e-04 | 172 | 36 | 4 | GO:0051783 | |
| GeneOntologyBiologicalProcess | regulation of secretion by cell | 2.50e-04 | 740 | 36 | 7 | GO:1903530 | |
| GeneOntologyBiologicalProcess | enteric nervous system development | 2.66e-04 | 14 | 36 | 2 | GO:0048484 | |
| GeneOntologyBiologicalProcess | protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway | 3.07e-04 | 15 | 36 | 2 | GO:0043328 | |
| GeneOntologyBiologicalProcess | meiotic cell cycle | 3.34e-04 | 350 | 36 | 5 | GO:0051321 | |
| GeneOntologyBiologicalProcess | positive regulation of exosomal secretion | 3.50e-04 | 16 | 36 | 2 | GO:1903543 | |
| GeneOntologyBiologicalProcess | anatomical structure maturation | 3.52e-04 | 354 | 36 | 5 | GO:0071695 | |
| GeneOntologyBiologicalProcess | regulation of secretion | 4.04e-04 | 801 | 36 | 7 | GO:0051046 | |
| GeneOntologyBiologicalProcess | nose development | 4.45e-04 | 18 | 36 | 2 | GO:0043584 | |
| GeneOntologyBiologicalProcess | mRNA catabolic process | 4.48e-04 | 373 | 36 | 5 | GO:0006402 | |
| GeneOntologyBiologicalProcess | Notch signaling pathway | 4.76e-04 | 210 | 36 | 4 | GO:0007219 | |
| GeneOntologyBiologicalProcess | regulation of exosomal secretion | 5.52e-04 | 20 | 36 | 2 | GO:1903541 | |
| GeneOntologyBiologicalProcess | female gamete generation | 5.97e-04 | 223 | 36 | 4 | GO:0007292 | |
| GeneOntologyBiologicalProcess | regulation of clathrin-dependent endocytosis | 6.09e-04 | 21 | 36 | 2 | GO:2000369 | |
| GeneOntologyBiologicalProcess | positive regulation of secretion by cell | 6.43e-04 | 404 | 36 | 5 | GO:1903532 | |
| GeneOntologyBiologicalProcess | positive regulation of cell cycle | 6.65e-04 | 407 | 36 | 5 | GO:0045787 | |
| GeneOntologyBiologicalProcess | export from cell | 6.92e-04 | 1153 | 36 | 8 | GO:0140352 | |
| GeneOntologyBiologicalProcess | regulation of cellular response to growth factor stimulus | 7.02e-04 | 412 | 36 | 5 | GO:0090287 | |
| GeneOntologyBiologicalProcess | positive regulation of protein metabolic process | 7.06e-04 | 1458 | 36 | 9 | GO:0051247 | |
| GeneOntologyBiologicalProcess | negative regulation of catabolic process | 7.50e-04 | 418 | 36 | 5 | GO:0009895 | |
| GeneOntologyBiologicalProcess | response to estrogen | 7.66e-04 | 103 | 36 | 3 | GO:0043627 | |
| GeneOntologyBiologicalProcess | roof of mouth development | 7.88e-04 | 104 | 36 | 3 | GO:0060021 | |
| GeneOntologyBiologicalProcess | exosomal secretion | 7.98e-04 | 24 | 36 | 2 | GO:1990182 | |
| GeneOntologyBiologicalProcess | extracellular exosome biogenesis | 8.66e-04 | 25 | 36 | 2 | GO:0097734 | |
| GeneOntologyBiologicalProcess | RNA catabolic process | 8.69e-04 | 432 | 36 | 5 | GO:0006401 | |
| GeneOntologyBiologicalProcess | positive regulation of secretion | 8.97e-04 | 435 | 36 | 5 | GO:0051047 | |
| GeneOntologyBiologicalProcess | head development | 9.16e-04 | 919 | 36 | 7 | GO:0060322 | |
| GeneOntologyBiologicalProcess | regulation of reproductive process | 9.29e-04 | 251 | 36 | 4 | GO:2000241 | |
| GeneOntologyBiologicalProcess | developmental maturation | 9.34e-04 | 439 | 36 | 5 | GO:0021700 | |
| GeneOntologyBiologicalProcess | regulation of mRNA metabolic process | 9.73e-04 | 443 | 36 | 5 | GO:1903311 | |
| GeneOntologyBiologicalProcess | late endosome to vacuole transport via multivesicular body sorting pathway | 1.01e-03 | 27 | 36 | 2 | GO:0032511 | |
| GeneOntologyBiologicalProcess | secondary palate development | 1.01e-03 | 27 | 36 | 2 | GO:0062009 | |
| GeneOntologyBiologicalProcess | extracellular vesicle biogenesis | 1.01e-03 | 27 | 36 | 2 | GO:0140112 | |
| GeneOntologyBiologicalProcess | regulation of Notch signaling pathway | 1.03e-03 | 114 | 36 | 3 | GO:0008593 | |
| GeneOntologyBiologicalProcess | adrenal gland development | 1.17e-03 | 29 | 36 | 2 | GO:0030325 | |
| GeneOntologyBiologicalProcess | nucleobase-containing compound catabolic process | 1.19e-03 | 696 | 36 | 6 | GO:0034655 | |
| GeneOntologyBiologicalProcess | nucleic acid catabolic process | 1.20e-03 | 464 | 36 | 5 | GO:0141188 | |
| GeneOntologyBiologicalProcess | positive regulation of T-helper cell differentiation | 1.33e-03 | 31 | 36 | 2 | GO:0045624 | |
| GeneOntologyBiologicalProcess | germ cell development | 1.42e-03 | 482 | 36 | 5 | GO:0007281 | |
| GeneOntologyBiologicalProcess | multivesicular body assembly | 1.51e-03 | 33 | 36 | 2 | GO:0036258 | |
| GeneOntologyBiologicalProcess | multivesicular body organization | 1.60e-03 | 34 | 36 | 2 | GO:0036257 | |
| GeneOntologyBiologicalProcess | spermatogenesis | 1.67e-03 | 744 | 36 | 6 | GO:0007283 | |
| GeneOntologyBiologicalProcess | nuclear division | 1.85e-03 | 512 | 36 | 5 | GO:0000280 | |
| GeneOntologyBiologicalProcess | male gamete generation | 1.88e-03 | 762 | 36 | 6 | GO:0048232 | |
| GeneOntologyBiologicalProcess | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway | 1.90e-03 | 37 | 36 | 2 | GO:0043162 | |
| GeneOntologyBiologicalProcess | respiratory system development | 1.90e-03 | 305 | 36 | 4 | GO:0060541 | |
| GeneOntologyBiologicalProcess | positive regulation of cell cycle process | 1.95e-03 | 307 | 36 | 4 | GO:0090068 | |
| GeneOntologyBiologicalProcess | positive regulation of T cell differentiation | 2.01e-03 | 144 | 36 | 3 | GO:0045582 | |
| GeneOntologyBiologicalProcess | cellular process involved in reproduction in multicellular organism | 2.09e-03 | 527 | 36 | 5 | GO:0022412 | |
| GeneOntologyBiologicalProcess | late endosome to vacuole transport | 2.11e-03 | 39 | 36 | 2 | GO:0045324 | |
| GeneOntologyBiologicalProcess | secretion by cell | 2.14e-03 | 1064 | 36 | 7 | GO:0032940 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | 2.31e-03 | 1390 | 36 | 8 | GO:0045944 | |
| GeneOntologyBiologicalProcess | tube development | 2.43e-03 | 1402 | 36 | 8 | GO:0035295 | |
| GeneOntologyBiologicalProcess | endosome transport via multivesicular body sorting pathway | 2.56e-03 | 43 | 36 | 2 | GO:0032509 | |
| GeneOntologyBiologicalProcess | regulation of vascular endothelial growth factor receptor signaling pathway | 2.68e-03 | 44 | 36 | 2 | GO:0030947 | |
| GeneOntologyBiologicalProcess | translation | 2.79e-03 | 824 | 36 | 6 | GO:0006412 | |
| GeneOntologyCellularComponent | ESCRT-0 complex | 8.64e-06 | 3 | 36 | 2 | GO:0033565 | |
| GeneOntologyCellularComponent | transcription regulator complex | 6.01e-05 | 596 | 36 | 7 | GO:0005667 | |
| GeneOntologyCellularComponent | chromatin | 1.42e-04 | 1480 | 36 | 10 | GO:0000785 | |
| GeneOntologyCellularComponent | ribosome | 1.11e-03 | 267 | 36 | 4 | GO:0005840 | |
| GeneOntologyCellularComponent | SWI/SNF complex | 1.22e-03 | 30 | 36 | 2 | GO:0016514 | |
| GeneOntologyCellularComponent | ESCRT complex | 1.38e-03 | 32 | 36 | 2 | GO:0036452 | |
| GeneOntologyCellularComponent | calyx of Held | 1.75e-03 | 36 | 36 | 2 | GO:0044305 | |
| HumanPheno | Y-linked inheritance | 1.04e-05 | 18 | 13 | 3 | HP:0001450 | |
| HumanPheno | Oligozoospermia | 1.07e-05 | 59 | 13 | 4 | HP:0000798 | |
| HumanPheno | Decreased testicular size | 8.83e-05 | 200 | 13 | 5 | HP:0008734 | |
| HumanPheno | Aplasia/Hypoplasia of the testes | 1.42e-04 | 221 | 13 | 5 | HP:0010468 | |
| HumanPheno | Cryptorchidism | 1.83e-04 | 780 | 13 | 8 | HP:0000028 | |
| HumanPheno | Abnormality of the testis size | 2.02e-04 | 238 | 13 | 5 | HP:0045058 | |
| MousePheno | abnormal ovary size | 5.28e-07 | 228 | 31 | 7 | MP:0004853 | |
| MousePheno | small ovary | 2.21e-06 | 178 | 31 | 6 | MP:0001127 | |
| MousePheno | absent ovarian follicles | 4.60e-06 | 51 | 31 | 4 | MP:0002777 | |
| MousePheno | abnormal ovarian follicle number | 4.74e-06 | 203 | 31 | 6 | MP:0008871 | |
| MousePheno | abnormal female reproductive system physiology | 1.17e-05 | 876 | 31 | 10 | MP:0003699 | |
| MousePheno | abnormal ovarian follicle morphology | 1.39e-05 | 245 | 31 | 6 | MP:0001131 | |
| MousePheno | abnormal respiratory system development | 2.46e-05 | 160 | 31 | 5 | MP:0003115 | |
| MousePheno | female infertility | 2.54e-05 | 410 | 31 | 7 | MP:0001926 | |
| MousePheno | abnormal ovary morphology | 4.66e-05 | 451 | 31 | 7 | MP:0001126 | |
| MousePheno | abnormal solitary pulmonary neuroendocrine cell morphology | 4.74e-05 | 5 | 31 | 2 | MP:0010914 | |
| MousePheno | abnormal female reproductive gland morphology | 6.48e-05 | 475 | 31 | 7 | MP:0013324 | |
| MousePheno | abnormal pituitary hormone level | 9.86e-05 | 214 | 31 | 5 | MP:0003965 | |
| MousePheno | abnormal hepatic diverticulum morphology | 1.32e-04 | 8 | 31 | 2 | MP:0012234 | |
| MousePheno | abnormal liver bud morphology | 1.32e-04 | 8 | 31 | 2 | MP:0012235 | |
| MousePheno | abnormal sex determination | 1.47e-04 | 945 | 31 | 9 | MP:0002210 | |
| MousePheno | abnormal internal female genitalia morphology | 1.85e-04 | 757 | 31 | 8 | MP:0009209 | |
| MousePheno | abnormal female genitalia morphology | 1.95e-04 | 763 | 31 | 8 | MP:0009208 | |
| MousePheno | abnormal female reproductive system morphology | 2.00e-04 | 766 | 31 | 8 | MP:0001119 | |
| MousePheno | abnormal lung development | 2.59e-04 | 142 | 31 | 4 | MP:0001176 | |
| MousePheno | small gonad | 5.33e-04 | 885 | 31 | 8 | MP:0001116 | |
| MousePheno | abnormal neuronal precursor proliferation | 5.75e-04 | 74 | 31 | 3 | MP:0004948 | |
| MousePheno | abnormal primary sex determination | 6.01e-04 | 901 | 31 | 8 | MP:0002211 | |
| MousePheno | abnormal neuroendocrine cell morphology | 6.34e-04 | 17 | 31 | 2 | MP:0010913 | |
| MousePheno | absent olfactory bulb | 6.34e-04 | 17 | 31 | 2 | MP:0003451 | |
| MousePheno | abnormal epicardium morphology | 6.34e-04 | 17 | 31 | 2 | MP:0003057 | |
| MousePheno | abnormal circulating alanine transaminase level | 6.83e-04 | 498 | 31 | 6 | MP:0001573 | |
| MousePheno | decreased fetal cardiomyocyte proliferation | 7.12e-04 | 18 | 31 | 2 | MP:0011395 | |
| MousePheno | thin myocardium | 8.62e-04 | 85 | 31 | 3 | MP:0002652 | |
| MousePheno | absent placental labyrinth | 9.74e-04 | 21 | 31 | 2 | MP:0003403 | |
| MousePheno | abnormal follicle stimulating hormone level | 9.86e-04 | 89 | 31 | 3 | MP:0003967 | |
| MousePheno | abnormal prenatal growth/weight/body size | 1.01e-03 | 1493 | 31 | 10 | MP:0004196 | |
| MousePheno | abnormal digestive system morphology | 1.06e-03 | 1233 | 31 | 9 | MP:0000462 | |
| MousePheno | abnormal enteric neuron morphology | 1.07e-03 | 22 | 31 | 2 | MP:0001046 | |
| Domain | RRM_1 | 4.65e-05 | 208 | 36 | 5 | PF00076 | |
| Domain | RRM | 5.68e-05 | 217 | 36 | 5 | SM00360 | |
| Domain | RRM_dom | 7.04e-05 | 227 | 36 | 5 | IPR000504 | |
| Domain | RRM | 7.49e-05 | 230 | 36 | 5 | PS50102 | |
| Domain | - | 9.89e-05 | 244 | 36 | 5 | 3.30.70.330 | |
| Domain | SANT | 1.21e-04 | 50 | 36 | 3 | SM00717 | |
| Domain | Nucleotide-bd_a/b_plait | 1.29e-04 | 258 | 36 | 5 | IPR012677 | |
| Domain | VHS | 1.29e-04 | 9 | 36 | 2 | SM00288 | |
| Domain | VHS_dom | 1.29e-04 | 9 | 36 | 2 | IPR002014 | |
| Domain | VHS | 1.29e-04 | 9 | 36 | 2 | PF00790 | |
| Domain | VHS | 1.29e-04 | 9 | 36 | 2 | PS50179 | |
| Domain | SANT/Myb | 1.36e-04 | 52 | 36 | 3 | IPR001005 | |
| Domain | UIM | 5.42e-04 | 18 | 36 | 2 | PF02809 | |
| Domain | UIM | 7.41e-04 | 21 | 36 | 2 | SM00726 | |
| Domain | UIM | 9.71e-04 | 24 | 36 | 2 | PS50330 | |
| Domain | UIM_dom | 1.05e-03 | 25 | 36 | 2 | IPR003903 | |
| Domain | - | 1.14e-03 | 26 | 36 | 2 | 1.25.40.90 | |
| Domain | SANT_dom | 1.14e-03 | 26 | 36 | 2 | IPR017884 | |
| Domain | Bromodomain_CS | 1.14e-03 | 26 | 36 | 2 | IPR018359 | |
| Domain | SANT | 1.32e-03 | 28 | 36 | 2 | PS51293 | |
| Domain | ENTH_VHS | 1.42e-03 | 29 | 36 | 2 | IPR008942 | |
| Domain | CHROMO | 1.84e-03 | 33 | 36 | 2 | SM00298 | |
| Domain | Chromo/shadow_dom | 1.84e-03 | 33 | 36 | 2 | IPR000953 | |
| Domain | Myb_DNA-binding | 2.07e-03 | 35 | 36 | 2 | PF00249 | |
| Domain | BROMODOMAIN_1 | 2.31e-03 | 37 | 36 | 2 | PS00633 | |
| Domain | MYB_LIKE | 2.43e-03 | 38 | 36 | 2 | PS50090 | |
| Domain | Bromodomain | 2.43e-03 | 38 | 36 | 2 | PF00439 | |
| Domain | Znf_FYVE_PHD | 2.82e-03 | 147 | 36 | 3 | IPR011011 | |
| Domain | BROMODOMAIN_2 | 2.83e-03 | 41 | 36 | 2 | PS50014 | |
| Domain | BROMO | 2.96e-03 | 42 | 36 | 2 | SM00297 | |
| Domain | Bromodomain | 2.96e-03 | 42 | 36 | 2 | IPR001487 | |
| Domain | - | 2.96e-03 | 42 | 36 | 2 | 1.20.920.10 | |
| Domain | Homeodomain-like | 3.69e-03 | 332 | 36 | 4 | IPR009057 | |
| Domain | Zinc_finger_PHD-type_CS | 6.96e-03 | 65 | 36 | 2 | IPR019786 | |
| Pathway | WP_OVARIAN_INFERTILITY | 8.33e-07 | 35 | 30 | 4 | MM15948 | |
| Pathway | WP_MECHANISMS_ASSOCIATED_WITH_PLURIPOTENCY | 2.52e-06 | 301 | 30 | 7 | MM15983 | |
| Pathway | WP_MALE_INFERTILITY | 1.24e-05 | 145 | 30 | 5 | M39856 | |
| Pathway | REACTOME_REGULATION_OF_GENE_EXPRESSION_BY_HYPOXIA_INDUCIBLE_FACTOR | 6.53e-05 | 6 | 30 | 2 | MM14521 | |
| Pathway | PID_HES_HEY_PATHWAY | 1.41e-04 | 48 | 30 | 3 | M288 | |
| Pathway | REACTOME_RUNX3_REGULATES_NOTCH_SIGNALING | 1.95e-04 | 10 | 30 | 2 | MM15535 | |
| Pathway | REACTOME_REGULATION_OF_GENE_EXPRESSION_BY_HYPOXIA_INDUCIBLE_FACTOR | 2.38e-04 | 11 | 30 | 2 | M26924 | |
| Pathway | REACTOME_NOTCH2_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 2.85e-04 | 12 | 30 | 2 | M27159 | |
| Pathway | REACTOME_RUNX3_REGULATES_NOTCH_SIGNALING | 3.92e-04 | 14 | 30 | 2 | M27808 | |
| Pathway | BIOCARTA_HIF_PATHWAY | 4.52e-04 | 15 | 30 | 2 | M13324 | |
| Pathway | REACTOME_INLB_MEDIATED_ENTRY_OF_LISTERIA_MONOCYTOGENES_INTO_HOST_CELL | 4.52e-04 | 15 | 30 | 2 | M27774 | |
| Pathway | BIOCARTA_PITX2_PATHWAY | 4.52e-04 | 15 | 30 | 2 | MM1439 | |
| Pathway | BIOCARTA_PITX2_PATHWAY | 5.16e-04 | 16 | 30 | 2 | M8516 | |
| Pathway | REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_LATE_STAGE_BRANCHING_MORPHOGENESIS_PANCREATIC_BUD_PRECURSOR_CELLS | 5.16e-04 | 16 | 30 | 2 | M27121 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1 | 6.56e-04 | 18 | 30 | 2 | MM14775 | |
| Pathway | REACTOME_RORA_ACTIVATES_GENE_EXPRESSION | 6.56e-04 | 18 | 30 | 2 | M26942 | |
| Pathway | WP_DELTANOTCH_SIGNALING_PATHWAY | 6.88e-04 | 82 | 30 | 3 | MM15922 | |
| Pathway | REACTOME_LISTERIA_MONOCYTOGENES_ENTRY_INTO_HOST_CELLS | 8.12e-04 | 20 | 30 | 2 | M27780 | |
| Pathway | REACTOME_NOTCH4_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 8.12e-04 | 20 | 30 | 2 | M27881 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_MET_ACTIVITY | 8.97e-04 | 21 | 30 | 2 | M27645 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_MET_ACTIVITY | 8.97e-04 | 21 | 30 | 2 | MM15347 | |
| Pathway | WP_KALLMANN_SYNDROME | 1.17e-03 | 24 | 30 | 2 | M42530 | |
| Pathway | BIOCARTA_VDR_PATHWAY | 1.17e-03 | 24 | 30 | 2 | M13404 | |
| Pathway | REACTOME_NOTCH3_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 1.27e-03 | 25 | 30 | 2 | M27880 | |
| Pathway | REACTOME_CARGO_RECOGNITION_FOR_CLATHRIN_MEDIATED_ENDOCYTOSIS | 1.30e-03 | 102 | 30 | 3 | MM15498 | |
| Pathway | REACTOME_FORMATION_OF_THE_BETA_CATENIN_TCF_TRANSACTIVATING_COMPLEX | 1.38e-03 | 26 | 30 | 2 | MM14793 | |
| Pathway | REACTOME_CARGO_RECOGNITION_FOR_CLATHRIN_MEDIATED_ENDOCYTOSIS | 1.41e-03 | 105 | 30 | 3 | M27752 | |
| Pathway | WP_KLEEFSTRA_SYNDROME | 1.72e-03 | 29 | 30 | 2 | M48076 | |
| Pathway | REACTOME_METALLOPROTEASE_DUBS | 1.72e-03 | 29 | 30 | 2 | MM15291 | |
| Pathway | REACTOME_ENDOSOMAL_SORTING_COMPLEX_REQUIRED_FOR_TRANSPORT_ESCRT | 1.96e-03 | 31 | 30 | 2 | M1009 | |
| Pathway | REACTOME_EGFR_DOWNREGULATION | 1.96e-03 | 31 | 30 | 2 | MM14705 | |
| Pathway | REACTOME_EGFR_DOWNREGULATION | 1.96e-03 | 31 | 30 | 2 | M16597 | |
| Pathway | REACTOME_ENDOSOMAL_SORTING_COMPLEX_REQUIRED_FOR_TRANSPORT_ESCRT | 1.96e-03 | 31 | 30 | 2 | MM15637 | |
| Pathway | REACTOME_REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA | 1.97e-03 | 118 | 30 | 3 | M27316 | |
| Pathway | WP_VEGFAVEGFR2_SIGNALING | 1.98e-03 | 431 | 30 | 5 | M39729 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH2 | 2.22e-03 | 33 | 30 | 2 | M604 | |
| Pathway | WP_TYPE_2_PAPILLARY_RENAL_CELL_CARCINOMA | 2.35e-03 | 34 | 30 | 2 | M39771 | |
| Pathway | PID_HIF2PATHWAY | 2.35e-03 | 34 | 30 | 2 | M44 | |
| Pathway | REACTOME_RUNX1_INTERACTS_WITH_CO_FACTORS_WHOSE_PRECISE_EFFECT_ON_RUNX1_TARGETS_IS_NOT_KNOWN | 2.35e-03 | 34 | 30 | 2 | MM15531 | |
| Pathway | WP_MRNA_PROCESSING | 2.41e-03 | 451 | 30 | 5 | MM15946 | |
| Pathway | REACTOME_METALLOPROTEASE_DUBS | 2.78e-03 | 37 | 30 | 2 | M27580 | |
| Pathway | REACTOME_RUNX1_INTERACTS_WITH_CO_FACTORS_WHOSE_PRECISE_EFFECT_ON_RUNX1_TARGETS_IS_NOT_KNOWN | 2.78e-03 | 37 | 30 | 2 | M27797 | |
| Pathway | REACTOME_NGF_STIMULATED_TRANSCRIPTION | 3.09e-03 | 39 | 30 | 2 | M29793 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH | 3.09e-03 | 39 | 30 | 2 | MM14604 | |
| Pathway | REACTOME_RHOU_GTPASE_CYCLE | 3.09e-03 | 39 | 30 | 2 | MM15607 | |
| Pathway | REACTOME_RHOU_GTPASE_CYCLE | 3.25e-03 | 40 | 30 | 2 | M41816 | |
| Pathway | REACTOME_CLATHRIN_MEDIATED_ENDOCYTOSIS | 3.33e-03 | 142 | 30 | 3 | MM15499 | |
| Pathway | REACTOME_CLATHRIN_MEDIATED_ENDOCYTOSIS | 3.53e-03 | 145 | 30 | 3 | M27753 | |
| Pathway | REACTOME_REGULATION_OF_BETA_CELL_DEVELOPMENT | 3.58e-03 | 42 | 30 | 2 | M17541 | |
| Pathway | WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2873 | 4.09e-03 | 45 | 30 | 2 | M39615 | |
| Pathway | WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2586 | 4.28e-03 | 46 | 30 | 2 | M39661 | |
| Pathway | KEGG_NOTCH_SIGNALING_PATHWAY | 4.46e-03 | 47 | 30 | 2 | M7946 | |
| Pathway | REACTOME_TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT | 4.49e-03 | 158 | 30 | 3 | MM14791 | |
| Pathway | REACTOME_NOTCH1_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 4.65e-03 | 48 | 30 | 2 | M611 | |
| Pathway | KEGG_PATHWAYS_IN_CANCER | 4.73e-03 | 325 | 30 | 4 | M12868 | |
| Pathway | REACTOME_HEME_SIGNALING | 4.84e-03 | 49 | 30 | 2 | M41832 | |
| Pathway | REACTOME_SIGNALING_BY_EGFR | 4.84e-03 | 49 | 30 | 2 | MM14695 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH3 | 4.84e-03 | 49 | 30 | 2 | M618 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | 4.90e-03 | 532 | 30 | 5 | M27870 | |
| Pubmed | Analysis of the DAZ gene family in cryptorchidism and idiopathic male infertility. | 9.66e-13 | 4 | 36 | 4 | 15066457 | |
| Pubmed | 9.66e-13 | 4 | 36 | 4 | 7670487 | ||
| Pubmed | Impact of partial DAZ1/2 deletion and partial DAZ3/4 deletion on male infertility. | 9.66e-13 | 4 | 36 | 4 | 26232607 | |
| Pubmed | 9.66e-13 | 4 | 36 | 4 | 11694340 | ||
| Pubmed | 9.66e-13 | 4 | 36 | 4 | 9321470 | ||
| Pubmed | 9.66e-13 | 4 | 36 | 4 | 19223287 | ||
| Pubmed | Male infertility caused by a de novo partial deletion of the DAZ cluster on the Y chromosome. | 9.66e-13 | 4 | 36 | 4 | 11095434 | |
| Pubmed | [Microdeletion of chromosome Y in male infertility: role of the DAZ gene]. | 9.66e-13 | 4 | 36 | 4 | 11688365 | |
| Pubmed | 9.66e-13 | 4 | 36 | 4 | 12752250 | ||
| Pubmed | A novel approach for the analysis of DAZ gene copy number in severely idiopathic infertile men. | 9.66e-13 | 4 | 36 | 4 | 11883873 | |
| Pubmed | Four DAZ genes in two clusters found in the AZFc region of the human Y chromosome. | 9.66e-13 | 4 | 36 | 4 | 10936047 | |
| Pubmed | [Study on DAZ gene copy deletion in severe oligozoospermia sperm donor for ICSI]. | 9.66e-13 | 4 | 36 | 4 | 16963411 | |
| Pubmed | Partial DAZ deletions in a family with five infertile brothers. | 9.66e-13 | 4 | 36 | 4 | 12801575 | |
| Pubmed | 4.83e-12 | 5 | 36 | 4 | 23298641 | ||
| Pubmed | 4.83e-12 | 5 | 36 | 4 | 23579190 | ||
| Pubmed | DAZL is essential for stress granule formation implicated in germ cell survival upon heat stress. | 4.83e-12 | 5 | 36 | 4 | 22223682 | |
| Pubmed | Kinked β-strands mediate high-affinity recognition of mRNA targets by the germ-cell regulator DAZL. | 4.83e-12 | 5 | 36 | 4 | 22021443 | |
| Pubmed | The mouse Dazla gene encodes a cytoplasmic protein essential for gametogenesis. | 4.83e-12 | 5 | 36 | 4 | 9288969 | |
| Pubmed | 4.83e-12 | 5 | 36 | 4 | 20008336 | ||
| Pubmed | 4.83e-12 | 5 | 36 | 4 | 23456578 | ||
| Pubmed | Isolation of a mouse homolog of the human DAZ (Deleted in Azoospermia) gene. | 4.83e-12 | 5 | 36 | 4 | 8679003 | |
| Pubmed | A human DAZ transgene confers partial rescue of the mouse Dazl null phenotype. | 4.83e-12 | 5 | 36 | 4 | 10393944 | |
| Pubmed | The human autosomal gene DAZLA: testis specificity and a candidate for male infertility. | 4.83e-12 | 5 | 36 | 4 | 8968756 | |
| Pubmed | 4.83e-12 | 5 | 36 | 4 | 8968755 | ||
| Pubmed | DAZL Regulates Germ Cell Survival through a Network of PolyA-Proximal mRNA Interactions. | 4.83e-12 | 5 | 36 | 4 | 30380414 | |
| Pubmed | Regulated Formation of an Amyloid-like Translational Repressor Governs Gametogenesis. | 4.83e-12 | 5 | 36 | 4 | 26411291 | |
| Pubmed | In vivo and in vitro analysis of homodimerisation activity of the mouse Dazl1 protein. | 4.83e-12 | 5 | 36 | 4 | 10903443 | |
| Pubmed | Germline DNA demethylation dynamics and imprint erasure through 5-hydroxymethylcytosine. | 4.83e-12 | 5 | 36 | 4 | 23223451 | |
| Pubmed | 4.83e-12 | 5 | 36 | 4 | 34985827 | ||
| Pubmed | 4.83e-12 | 5 | 36 | 4 | 11804965 | ||
| Pubmed | 4.83e-12 | 5 | 36 | 4 | 9143498 | ||
| Pubmed | Expression profiling of the developing testis in wild-type and Dazl knockout mice. | 4.83e-12 | 5 | 36 | 4 | 14648873 | |
| Pubmed | Bisphenol A exposure modifies DNA methylation of imprint genes in mouse fetal germ cells. | 4.83e-12 | 5 | 36 | 4 | 22699882 | |
| Pubmed | A murine homologue of the human DAZ gene is autosomal and expressed only in male and female gonads. | 4.83e-12 | 5 | 36 | 4 | 8845845 | |
| Pubmed | 4.83e-12 | 5 | 36 | 4 | 8896558 | ||
| Pubmed | 4.83e-12 | 5 | 36 | 4 | 11058556 | ||
| Pubmed | AZFc partial deletions in Chilean men with severe spermatogenic failure. | 4.83e-12 | 5 | 36 | 4 | 17416365 | |
| Pubmed | Dazl promotes germ cell differentiation from embryonic stem cells. | 4.83e-12 | 5 | 36 | 4 | 19783541 | |
| Pubmed | 4.83e-12 | 5 | 36 | 4 | 22293198 | ||
| Pubmed | 4.83e-12 | 5 | 36 | 4 | 17761180 | ||
| Pubmed | 4.83e-12 | 5 | 36 | 4 | 19468308 | ||
| Pubmed | 4.83e-12 | 5 | 36 | 4 | 9700189 | ||
| Pubmed | Partial rescue of the Dazl knockout mouse by the human DAZL gene. | 4.83e-12 | 5 | 36 | 4 | 12200456 | |
| Pubmed | 4.83e-12 | 5 | 36 | 4 | 11514340 | ||
| Pubmed | 4.83e-12 | 5 | 36 | 4 | 21270429 | ||
| Pubmed | 4.83e-12 | 5 | 36 | 4 | 11089564 | ||
| Pubmed | 4.83e-12 | 5 | 36 | 4 | 8661148 | ||
| Pubmed | 1.45e-11 | 6 | 36 | 4 | 32170089 | ||
| Pubmed | Expression profiles of the DAZ gene family in human testis with and without spermatogenic failure. | 1.45e-11 | 6 | 36 | 4 | 15066460 | |
| Pubmed | 1.45e-11 | 6 | 36 | 4 | 16278232 | ||
| Pubmed | 1.45e-11 | 6 | 36 | 4 | 20157580 | ||
| Pubmed | DAZL binds to the transcripts of several Tssk genes in germ cells. | 1.45e-11 | 6 | 36 | 4 | 18452650 | |
| Pubmed | 1.45e-11 | 6 | 36 | 4 | 17219433 | ||
| Pubmed | 1.45e-11 | 6 | 36 | 4 | 28496037 | ||
| Pubmed | DAZL regulates Tet1 translation in murine embryonic stem cells. | 1.45e-11 | 6 | 36 | 4 | 26077710 | |
| Pubmed | The DAZL family proteins are PABP-binding proteins that regulate translation in germ cells. | 1.45e-11 | 6 | 36 | 4 | 16001084 | |
| Pubmed | 1.45e-11 | 6 | 36 | 4 | 32962040 | ||
| Pubmed | 1.45e-11 | 6 | 36 | 4 | 17526644 | ||
| Pubmed | Genetic mapping of a male germ cell-expressed gene Tpx-2 to mouse chromosome 17. | 1.45e-11 | 6 | 36 | 4 | 1869307 | |
| Pubmed | 1.45e-11 | 6 | 36 | 4 | 11390979 | ||
| Pubmed | 1.45e-11 | 6 | 36 | 4 | 24086306 | ||
| Pubmed | 1.45e-11 | 6 | 36 | 4 | 27632217 | ||
| Pubmed | 1.45e-11 | 6 | 36 | 4 | 1638086 | ||
| Pubmed | Spermatogenesis in testes of Dazl null mice after transplantation of wild-type germ cells. | 1.45e-11 | 6 | 36 | 4 | 14611632 | |
| Pubmed | DAZL binds to 3'UTR of Tex19.1 mRNAs and regulates Tex19.1 expression. | 1.45e-11 | 6 | 36 | 4 | 19247806 | |
| Pubmed | DAZL is a master translational regulator of murine spermatogenesis. | 1.45e-11 | 6 | 36 | 4 | 31355046 | |
| Pubmed | The fate of granulosa cells following premature oocyte loss and the development of ovarian cancers. | 1.45e-11 | 6 | 36 | 4 | 23417416 | |
| Pubmed | 3.38e-11 | 7 | 36 | 4 | 11410654 | ||
| Pubmed | 3.38e-11 | 7 | 36 | 4 | 15081113 | ||
| Pubmed | 3.38e-11 | 7 | 36 | 4 | 22699423 | ||
| Pubmed | 3.38e-11 | 7 | 36 | 4 | 11604102 | ||
| Pubmed | 3.38e-11 | 7 | 36 | 4 | 10857750 | ||
| Pubmed | The Dazh gene is expressed in male and female embryonic gonads before germ cell sex differentiation. | 3.38e-11 | 7 | 36 | 4 | 9588208 | |
| Pubmed | DAZL and CPEB1 regulate mRNA translation synergistically during oocyte maturation. | 3.38e-11 | 7 | 36 | 4 | 26826184 | |
| Pubmed | Dazl can bind to dynein motor complex and may play a role in transport of specific mRNAs. | 3.38e-11 | 7 | 36 | 4 | 16946704 | |
| Pubmed | 6.75e-11 | 8 | 36 | 4 | 10951504 | ||
| Pubmed | 6.75e-11 | 8 | 36 | 4 | 33749946 | ||
| Pubmed | Hypomethylating therapy in an aggressive stroma-rich model of pancreatic carcinoma. | 6.75e-11 | 8 | 36 | 4 | 23204224 | |
| Pubmed | 6.75e-11 | 8 | 36 | 4 | 29883445 | ||
| Pubmed | Mouse dead end1 acts with Nanos2 and Nanos3 to regulate testicular teratoma incidence. | 6.75e-11 | 8 | 36 | 4 | 32339196 | |
| Pubmed | 6.75e-11 | 8 | 36 | 4 | 10823932 | ||
| Pubmed | 6.75e-11 | 8 | 36 | 4 | 22621333 | ||
| Pubmed | 6.75e-11 | 8 | 36 | 4 | 32686646 | ||
| Pubmed | 6.75e-11 | 8 | 36 | 4 | 11869379 | ||
| Pubmed | Interaction network of human early embryonic transcription factors. | 7.26e-11 | 351 | 36 | 9 | 38297188 | |
| Pubmed | A Gene Regulatory Program for Meiotic Prophase in the Fetal Ovary. | 1.21e-10 | 9 | 36 | 4 | 26378784 | |
| Pubmed | Dazl deficiency leads to embryonic arrest of germ cell development in XY C57BL/6 mice. | 1.21e-10 | 9 | 36 | 4 | 16310179 | |
| Pubmed | Embryoid bodies from mouse stem cells express oxytocin receptor, Oct-4 and DAZL. | 1.21e-10 | 9 | 36 | 4 | 19695304 | |
| Pubmed | 1.21e-10 | 9 | 36 | 4 | 28235998 | ||
| Pubmed | 1.21e-10 | 9 | 36 | 4 | 20159962 | ||
| Pubmed | 2.02e-10 | 10 | 36 | 4 | 10601091 | ||
| Pubmed | 2.02e-10 | 10 | 36 | 4 | 31234534 | ||
| Pubmed | Tesmin transcription is regulated differently during male and female meiosis. | 2.02e-10 | 10 | 36 | 4 | 14648882 | |
| Pubmed | MAX controls meiotic entry in sexually undifferentiated germ cells. | 2.02e-10 | 10 | 36 | 4 | 38433229 | |
| Pubmed | 2.02e-10 | 10 | 36 | 4 | 9922113 | ||
| Pubmed | 2.02e-10 | 10 | 36 | 4 | 23810942 | ||
| Pubmed | 2.02e-10 | 10 | 36 | 4 | 12837688 | ||
| Pubmed | NANOS2 suppresses the cell cycle by repressing mTORC1 activators in embryonic male germ cells. | 3.17e-10 | 11 | 36 | 4 | 34401671 | |
| Pubmed | Retinoic acid activates two pathways required for meiosis in mice. | 4.76e-10 | 12 | 36 | 4 | 25102060 | |
| Pubmed | 4.76e-10 | 12 | 36 | 4 | 32054698 | ||
| Interaction | CRX interactions | 4.87e-10 | 254 | 36 | 9 | int:CRX | |
| Interaction | SP7 interactions | 2.37e-09 | 304 | 36 | 9 | int:SP7 | |
| Interaction | ERG interactions | 4.59e-09 | 223 | 36 | 8 | int:ERG | |
| Interaction | PAX6 interactions | 1.19e-08 | 366 | 36 | 9 | int:PAX6 | |
| Interaction | EGR2 interactions | 1.90e-08 | 171 | 36 | 7 | int:EGR2 | |
| Interaction | HNF4A interactions | 2.36e-08 | 275 | 36 | 8 | int:HNF4A | |
| Interaction | TBXT interactions | 5.40e-08 | 116 | 36 | 6 | int:TBXT | |
| Interaction | FEV interactions | 6.18e-08 | 203 | 36 | 7 | int:FEV | |
| Interaction | ASF1A interactions | 2.48e-07 | 249 | 36 | 7 | int:ASF1A | |
| Interaction | TLE3 interactions | 2.61e-07 | 376 | 36 | 8 | int:TLE3 | |
| Interaction | NUP35 interactions | 6.49e-07 | 424 | 36 | 8 | int:NUP35 | |
| Interaction | SOX9 interactions | 7.80e-07 | 97 | 36 | 5 | int:SOX9 | |
| Interaction | GATA2 interactions | 1.31e-06 | 199 | 36 | 6 | int:GATA2 | |
| Interaction | PAX7 interactions | 2.63e-06 | 124 | 36 | 5 | int:PAX7 | |
| Interaction | PAX9 interactions | 3.32e-06 | 130 | 36 | 5 | int:PAX9 | |
| Interaction | EYA4 interactions | 4.16e-06 | 243 | 36 | 6 | int:EYA4 | |
| Interaction | DUXB interactions | 4.19e-06 | 18 | 36 | 3 | int:DUXB | |
| Interaction | TLX3 interactions | 1.16e-05 | 291 | 36 | 6 | int:TLX3 | |
| Interaction | SOX7 interactions | 1.36e-05 | 82 | 36 | 4 | int:SOX7 | |
| Interaction | HNF1B interactions | 2.10e-05 | 190 | 36 | 5 | int:HNF1B | |
| Interaction | SOX17 interactions | 2.43e-05 | 95 | 36 | 4 | int:SOX17 | |
| Interaction | SS18L1 interactions | 2.75e-05 | 98 | 36 | 4 | int:SS18L1 | |
| Interaction | PAX8 interactions | 4.48e-05 | 111 | 36 | 4 | int:PAX8 | |
| Interaction | AR interactions | 4.62e-05 | 992 | 36 | 9 | int:AR | |
| Interaction | TBR1 interactions | 4.81e-05 | 113 | 36 | 4 | int:TBR1 | |
| Interaction | NPAS2 interactions | 5.73e-05 | 42 | 36 | 3 | int:NPAS2 | |
| Interaction | BOLL interactions | 5.73e-05 | 42 | 36 | 3 | int:BOLL | |
| Interaction | CREBBP interactions | 7.80e-05 | 599 | 36 | 7 | int:CREBBP | |
| Interaction | NCOA2 interactions | 1.14e-04 | 141 | 36 | 4 | int:NCOA2 | |
| Interaction | PUM2 interactions | 1.23e-04 | 144 | 36 | 4 | int:PUM2 | |
| Interaction | NCOA1 interactions | 1.30e-04 | 146 | 36 | 4 | int:NCOA1 | |
| Interaction | ELF5 interactions | 1.33e-04 | 147 | 36 | 4 | int:ELF5 | |
| Interaction | RBBP5 interactions | 1.49e-04 | 287 | 36 | 5 | int:RBBP5 | |
| Interaction | TSG101 interactions | 1.91e-04 | 303 | 36 | 5 | int:TSG101 | |
| Interaction | DEAF1 interactions | 2.02e-04 | 64 | 36 | 3 | int:DEAF1 | |
| Interaction | FOS interactions | 2.19e-04 | 312 | 36 | 5 | int:FOS | |
| Interaction | ASCL2 interactions | 2.39e-04 | 13 | 36 | 2 | int:ASCL2 | |
| Interaction | GCM1 interactions | 2.42e-04 | 68 | 36 | 3 | int:GCM1 | |
| Interaction | ETV4 interactions | 2.53e-04 | 69 | 36 | 3 | int:ETV4 | |
| Interaction | TLX1 interactions | 2.60e-04 | 175 | 36 | 4 | int:TLX1 | |
| Interaction | NR3C1 interactions | 2.61e-04 | 974 | 36 | 8 | int:NR3C1 | |
| Interaction | TEAD1 interactions | 2.66e-04 | 176 | 36 | 4 | int:TEAD1 | |
| Interaction | PPP1R2B interactions | 2.79e-04 | 14 | 36 | 2 | int:PPP1R2B | |
| Interaction | LHX3 interactions | 3.22e-04 | 185 | 36 | 4 | int:LHX3 | |
| Interaction | CELA2A interactions | 3.66e-04 | 16 | 36 | 2 | int:CELA2A | |
| Interaction | CLTA interactions | 3.77e-04 | 351 | 36 | 5 | int:CLTA | |
| Interaction | MYOD1 interactions | 3.85e-04 | 194 | 36 | 4 | int:MYOD1 | |
| Interaction | CYP1B1 interactions | 4.66e-04 | 18 | 36 | 2 | int:CYP1B1 | |
| Interaction | IRF4 interactions | 4.68e-04 | 85 | 36 | 3 | int:IRF4 | |
| Interaction | GSC interactions | 5.01e-04 | 87 | 36 | 3 | int:GSC | |
| Interaction | SS18 interactions | 5.18e-04 | 88 | 36 | 3 | int:SS18 | |
| Interaction | TBX19 interactions | 5.78e-04 | 20 | 36 | 2 | int:TBX19 | |
| Interaction | FOXI1 interactions | 5.89e-04 | 92 | 36 | 3 | int:FOXI1 | |
| Interaction | IST1 interactions | 6.28e-04 | 94 | 36 | 3 | int:IST1 | |
| Interaction | DPF3 interactions | 6.47e-04 | 95 | 36 | 3 | int:DPF3 | |
| Interaction | NFIX interactions | 6.96e-04 | 227 | 36 | 4 | int:NFIX | |
| Interaction | BAG2 interactions | 7.46e-04 | 622 | 36 | 6 | int:BAG2 | |
| Interaction | LHX1 interactions | 8.19e-04 | 103 | 36 | 3 | int:LHX1 | |
| Interaction | FRAS1 interactions | 8.19e-04 | 103 | 36 | 3 | int:FRAS1 | |
| Interaction | NR6A1 interactions | 8.35e-04 | 24 | 36 | 2 | int:NR6A1 | |
| Interaction | STAMBP interactions | 8.42e-04 | 104 | 36 | 3 | int:STAMBP | |
| Cytoband | Yq11.223 | 8.84e-07 | 93 | 36 | 4 | Yq11.223 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chrYq11 | 1.03e-04 | 311 | 36 | 4 | chrYq11 | |
| Cytoband | 22q13.2 | 1.03e-03 | 60 | 36 | 2 | 22q13.2 | |
| GeneFamily | ESCRT-0 | 6.44e-06 | 3 | 27 | 2 | 1115 | |
| GeneFamily | RNA binding motif containing | 1.42e-05 | 213 | 27 | 5 | 725 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 6.62e-05 | 53 | 27 | 3 | 532 | |
| GeneFamily | PHD finger proteins | 7.93e-03 | 90 | 27 | 2 | 88 | |
| GeneFamily | Basic helix-loop-helix proteins | 1.17e-02 | 110 | 27 | 2 | 420 | |
| Coexpression | TESAR_JAK_TARGETS_MOUSE_ES_D3_DN | 1.47e-09 | 12 | 36 | 4 | MM742 | |
| Coexpression | SASAI_TARGETS_OF_CXCR6_AND_PTCH1_DN | 1.47e-09 | 12 | 36 | 4 | MM781 | |
| Coexpression | WAGSCHAL_EHMT2_TARGETS_UP | 2.60e-08 | 23 | 36 | 4 | MM1293 | |
| Coexpression | MATZUK_SPERMATOGONIA | 9.18e-08 | 31 | 36 | 4 | MM765 | |
| Coexpression | CHEN_ETV5_TARGETS_TESTIS | 1.19e-07 | 33 | 36 | 4 | MM701 | |
| Coexpression | MADAN_DPPA4_TARGETS | 5.87e-06 | 86 | 36 | 4 | MM1312 | |
| Coexpression | JACKSON_DNMT1_TARGETS_UP | 8.02e-06 | 93 | 36 | 4 | MM1185 | |
| Coexpression | THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_7DY_DN | 2.13e-05 | 634 | 36 | 7 | M40866 | |
| Coexpression | MCCABE_BOUND_BY_HOXC6 | 3.57e-05 | 461 | 36 | 6 | M6376 | |
| Coexpression | THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_NONRESPONDER_7DY_DN | 1.33e-04 | 72 | 36 | 3 | M40882 | |
| Coexpression | GSE18893_CTRL_VS_TNF_TREATED_TREG_2H_UP | 1.60e-04 | 200 | 36 | 4 | M7294 | |
| Coexpression | GSE43863_NAIVE_VS_MEMORY_TFH_CD4_TCELL_D150_LCMV_UP | 1.60e-04 | 200 | 36 | 4 | M9737 | |
| Coexpression | THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_28DY_DN | 1.99e-04 | 905 | 36 | 7 | M40865 | |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_DN | 2.04e-04 | 909 | 36 | 7 | M41018 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Igfbp6_Pltp|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.02e-06 | 124 | 36 | 4 | 36dfc702a570e1a1a6dde09f38badf9023ea7287 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_I-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.32e-05 | 180 | 36 | 4 | 810c7116007ee6668d3731e7ce1fcf697c7b24f6 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.35e-05 | 181 | 36 | 4 | 03a303cd2f366f09c18b118bbba6f5e3f95ad56c | |
| Drug | boron trichloride | 7.88e-11 | 6 | 36 | 4 | CID000025135 | |
| Drug | neocarzinostatin chromophore | 5.11e-10 | 288 | 36 | 9 | CID000447545 | |
| Drug | 2-chlorodideoxyadenosine | 6.82e-09 | 43 | 36 | 5 | CID000072194 | |
| Drug | desmethylazelastine | 9.45e-09 | 16 | 36 | 4 | CID000162558 | |
| Drug | dazmegrel | 2.01e-08 | 19 | 36 | 4 | CID000053555 | |
| Drug | YM 026 | 2.01e-08 | 19 | 36 | 4 | CID000004443 | |
| Drug | azafagomine | 2.92e-08 | 57 | 36 | 5 | CID011957435 | |
| Drug | AZFd | 4.56e-08 | 23 | 36 | 4 | CID000196489 | |
| Drug | dansylaziridine | 4.56e-08 | 23 | 36 | 4 | CID000104008 | |
| Drug | p11-13 | 1.18e-07 | 75 | 36 | 5 | CID000015759 | |
| Drug | d-gluconhydroximo-1,5-lactam | 1.61e-07 | 31 | 36 | 4 | CID000003479 | |
| Drug | Vistar | 2.99e-07 | 36 | 36 | 4 | CID000040896 | |
| Drug | 3-bromo-7-nitroindazole | 2.99e-07 | 36 | 36 | 4 | CID000001649 | |
| Drug | BW755C | 3.48e-07 | 93 | 36 | 5 | CID000047795 | |
| Drug | molybdenum disulfide | 6.22e-07 | 43 | 36 | 4 | CID000014823 | |
| Drug | propham | 6.83e-07 | 44 | 36 | 4 | CID000024685 | |
| Drug | carbonyl sulfide | 1.05e-06 | 116 | 36 | 5 | CID000010039 | |
| Drug | ridogrel | 1.35e-06 | 52 | 36 | 4 | CID005362391 | |
| Drug | NSC56408 | 2.75e-06 | 62 | 36 | 4 | CID000005604 | |
| Drug | kt S | 3.54e-06 | 66 | 36 | 4 | CID006399216 | |
| Drug | azelastine | 5.60e-06 | 74 | 36 | 4 | CID000002267 | |
| Drug | fludrocortisone acetate; Up 200; 1uM; MCF7; HG-U133A | 1.40e-05 | 197 | 36 | 5 | 282_UP | |
| Drug | bipy | 1.64e-05 | 97 | 36 | 4 | CID000001474 | |
| Drug | 3,4-dimethoxy-N-((2,2-dimethyl-2H-chromen-6-yl)methyl)-N-phenylbenzenesulfonamide | 2.42e-05 | 5 | 36 | 2 | ctd:C575894 | |
| Drug | NSC9700 | 2.88e-05 | 578 | 36 | 7 | CID000005408 | |
| Drug | TXB2 (thromboxane B2 | 3.55e-05 | 118 | 36 | 4 | CID000005461 | |
| Drug | Ketoconazole [65277-42-1]; Down 200; 7.6uM; HL60; HT_HG-U133A | 1.87e-04 | 181 | 36 | 4 | 1285_DN | |
| Drug | Rapamycin; Up 200; 0.1uM; PC3; HT_HG-U133A | 2.11e-04 | 187 | 36 | 4 | 1242_UP | |
| Drug | CP-320650-01 [172079-28-6]; Up 200; 10uM; MCF7; HT_HG-U133A | 2.29e-04 | 191 | 36 | 4 | 3905_UP | |
| Drug | SP600125 | 2.48e-04 | 362 | 36 | 5 | CID000008515 | |
| Drug | haloperidol; Up 200; 10uM; MCF7; HT_HG-U133A_EA | 2.53e-04 | 196 | 36 | 4 | 1041_UP | |
| Drug | Pyrimethamine [58-14-0]; Up 200; 16uM; PC3; HG-U133A | 2.53e-04 | 196 | 36 | 4 | 1894_UP | |
| Drug | Netilmicin sulfate [56931-57-2]; Down 200; 2.8uM; HL60; HT_HG-U133A | 2.53e-04 | 196 | 36 | 4 | 2963_DN | |
| Drug | CAY10397; Up 200; 10uM; PC3; HT_HG-U133A | 2.53e-04 | 196 | 36 | 4 | 7071_UP | |
| Drug | rosiglitazone; Down 200; 10uM; MCF7; HT_HG-U133A_EA | 2.58e-04 | 197 | 36 | 4 | 1013_DN | |
| Drug | Iproniazide phosphate [305-33-9]; Down 200; 14.4uM; PC3; HT_HG-U133A | 2.58e-04 | 197 | 36 | 4 | 6359_DN | |
| Drug | CP-944629 [668990-94-1]; Down 200; 10uM; PC3; HT_HG-U133A | 2.58e-04 | 197 | 36 | 4 | 7502_DN | |
| Drug | Procaine hydrochloride [51-05-8]; Down 200; 14.6uM; PC3; HT_HG-U133A | 2.58e-04 | 197 | 36 | 4 | 1796_DN | |
| Drug | haloperidol; Down 200; 10uM; MCF7; HT_HG-U133A | 2.63e-04 | 198 | 36 | 4 | 1669_DN | |
| Drug | Bromopride [4093-35-0]; Down 200; 11.6uM; MCF7; HT_HG-U133A | 2.63e-04 | 198 | 36 | 4 | 6037_DN | |
| Drug | Iopamidol [60166-93-0]; Up 200; 5.2uM; PC3; HT_HG-U133A | 2.63e-04 | 198 | 36 | 4 | 5832_UP | |
| Drug | Aspartic acid, N-acetyl (R,S) [997-55-7]; Down 200; 22.8uM; HL60; HT_HG-U133A | 2.63e-04 | 198 | 36 | 4 | 1329_DN | |
| Drug | Naloxone hydrochloride [357-08-4]; Up 200; 11uM; HL60; HG-U133A | 2.63e-04 | 198 | 36 | 4 | 2006_UP | |
| Drug | estradiol; Down 200; 0.01uM; PC3; HT_HG-U133A | 2.68e-04 | 199 | 36 | 4 | 5960_DN | |
| Drug | thioridazine hydrochloride; Down 200; 1uM; MCF7; HG-U133A | 2.68e-04 | 199 | 36 | 4 | 422_DN | |
| Drug | tamoxifen citrate; Up 200; 1uM; MCF7; HG-U133A | 2.68e-04 | 199 | 36 | 4 | 380_UP | |
| Drug | SB 202190; Up 200; 1uM; PC3; HT_HG-U133A | 2.68e-04 | 199 | 36 | 4 | 7058_UP | |
| Drug | Lorglumide sodium salt [97964-56-2]; Down 200; 8.4uM; HL60; HT_HG-U133A | 2.68e-04 | 199 | 36 | 4 | 3079_DN | |
| Drug | Oxolinic acid [14698-29-4]; Up 200; 15.4uM; PC3; HT_HG-U133A | 2.68e-04 | 199 | 36 | 4 | 5094_UP | |
| Disease | Male sterility due to Y-chromosome deletions | 1.30e-10 | 8 | 36 | 4 | C2931163 | |
| Disease | Partial chromosome Y deletion | 1.30e-10 | 8 | 36 | 4 | C1507149 | |
| Disease | Spermatogenic failure, Y-linked, 2 | 9.24e-07 | 16 | 36 | 3 | cv:C1839071 | |
| Disease | Spermatogenic Failure, Nonobstructive, Y-Linked | 9.24e-07 | 16 | 36 | 3 | C1839071 | |
| Disease | SPERMATOGENIC FAILURE, Y-LINKED, 2 | 9.24e-07 | 16 | 36 | 3 | 415000 | |
| Disease | granulocyte percentage of myeloid white cells | 3.12e-04 | 268 | 36 | 4 | EFO_0007997 | |
| Disease | Squamous cell carcinoma of lung | 7.01e-04 | 32 | 36 | 2 | C0149782 | |
| Disease | Colorectal Carcinoma | 1.54e-03 | 702 | 36 | 5 | C0009402 | |
| Disease | Small cell carcinoma of lung | 1.99e-03 | 54 | 36 | 2 | C0149925 | |
| Disease | Precursor Cell Lymphoblastic Leukemia Lymphoma | 2.53e-03 | 61 | 36 | 2 | C1961102 | |
| Disease | breast carcinoma (is_marker_for) | 2.96e-03 | 66 | 36 | 2 | DOID:3459 (is_marker_for) | |
| Disease | C-reactive protein measurement | 3.13e-03 | 1206 | 36 | 6 | EFO_0004458 | |
| Disease | Papillary thyroid carcinoma | 4.96e-03 | 86 | 36 | 2 | C0238463 | |
| Disease | nevus count, cutaneous melanoma | 5.54e-03 | 91 | 36 | 2 | EFO_0000389, EFO_0004632 | |
| Disease | Adenoid Cystic Carcinoma | 6.65e-03 | 100 | 36 | 2 | C0010606 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QQPPAQQPGQPEVFQ | 746 | P27540 | |
| QQPPWSQGGLPQPQQ | 1991 | Q09472 | |
| QPNLPLPAQQPFQPQ | 131 | Q99218 | |
| LPAQQPFQPQPVQPQ | 136 | Q99218 | |
| AGQQPQPQPAAAPQP | 571 | Q2M2I8 | |
| ILLGQGPPQQPPQQH | 421 | Q9NSY1 | |
| GPPQQPPQQHRVLQQ | 426 | Q9NSY1 | |
| VNPPPPPQFQNVWRN | 131 | Q13117 | |
| VNPPPPPQFQNVWRN | 131 | Q9NR90 | |
| IRAPYQQQQPQPQPP | 156 | Q9P2D1 | |
| LRAPPPPSPNQNNNA | 1171 | Q16720 | |
| QQPQQQQPPPPPRAG | 131 | Q14774 | |
| QQQQQPPPPQLQAPR | 646 | Q96JK9 | |
| PPPQPQAQGQAPINN | 391 | Q9P0K8 | |
| FFQPPPQSEQPQQPQ | 46 | P06850 | |
| QPGQQGLQPNLLPFP | 116 | Q9UKI9 | |
| PPGNMNFPSQPFNQP | 156 | Q9BRQ0 | |
| RPPQNNPLPQGFQQP | 456 | Q14686 | |
| GQQPPPPPQQQQSGQ | 86 | Q9UP38 | |
| QQQQPQPPQPPFPAG | 81 | Q92896 | |
| VNPPPPPQFQNVWRN | 131 | Q9NQZ3 | |
| VNPPPPPQFQNVWRN | 296 | Q9NQZ3 | |
| VNPPPPPQFQNVWRN | 461 | Q9NQZ3 | |
| AQPAQPPQAQPPQQR | 176 | Q8NE35 | |
| GAGQQPQPQPQQPFL | 11 | P50553 | |
| RNQSRPQPQPEPQLP | 66 | Q9NPZ5 | |
| NRQVFRQGPPPPNPV | 226 | Q6PJG2 | |
| VNPPPPPQFQNVWRN | 131 | Q86SG3 | |
| VNPPPPPQFQNVWRN | 296 | Q86SG3 | |
| QPQPPQYAPAPQQLQ | 201 | O75791 | |
| PLGLQQPQAQQPPQA | 636 | Q9NZM4 | |
| GNPQQPQAPPAGQPQ | 386 | P02812 | |
| PRQQQQQPPPLAVGP | 11 | Q68CR1 | |
| QQQQQPPPALPPGSQ | 956 | Q8TAQ2 | |
| GRNLPAPDQPQPPLQ | 86 | Q9H2A9 | |
| LPPHPQQLRYPPNQN | 531 | O15164 | |
| QPQPPPAGLPQNARA | 261 | Q9BW04 | |
| GQPQQLPAQPPQQYQ | 306 | Q92734 | |
| GGPPQQQPPVAQQPQ | 746 | O14964 | |
| QQPPVAQQPQAQGPP | 751 | O14964 | |
| PGGSQQPPQPQQPYS | 521 | Q92783 | |
| LPPQQQQPAQPGPAA | 36 | Q14003 | |
| PQQQQQRQRPPRPPP | 16 | Q5TBK1 |